Viagra Orodispersible Tablets Launched in China, Offering Rapid Onset and Enhanced Privacy for ED Patients

BEIJING, Oct. 26, 2020 /PRNewswire/ -- On the occasion of the 21st "Chinese Men's Health Day," "Viagra^®"Viagra Orally Disintegrating Tablets Launch Event" was grandly held in Beijing. Leading experts in the field of andrology from across China gathered together to jointly witness the classic medication for treating male erectile dysfunction (ED) -- Viagra.^®The new orally disintegrating tablet formulation has been officially launched. At the launch event, the compilation of the "Chinese Expert Consensus on the 20-Year Clinical Application of Sildenafil Citrate: Public Edition," jointly authored by a frontline expert group from the Chinese Society for Sexual Health and the Andrology Branch of the Chinese Medical Association, was officially initiated, with plans for its official release in early 2021.

Viagra Orally Disintegrating Tablets China Launch Ceremony

Love It, Enjoy It Now, LetED: No More Slogging Away

With the rapid development of the social economy and an accelerated pace of life, people's "sexual well-being" index is declining. Particularly in first- and second-tier cities, due to busy work schedules and excessive stress, the number of patients with erectile dysfunction (ED) is on the rise and trending toward younger demographics. In a real-world study focusing on men with newly diagnosed ED, one-quarter of the patients were under 40 years of age, and nearly 50% of young men reported severe ED.^[1]. In an online survey of 92,620 young men in China, 20.54% of men under the age of 40 had an Erection Hardness Score (EHS) of Grade I–II.^[2](Grade IV: normal; Grade III: mild ED; Grade II: moderate ED; Grade I: severe ED). Erectile dysfunction (ED) has seriously affected men's health and has become a topic of common concern for many couples.

As one of the most common sexual dysfunctions in men, erectile dysfunction (ED) not only affects men’s “sexual well-being” but also impairs the work performance of male professionals. According to a multinational survey report, the percentage of Chinese men with ED experiencing work impairment due to the condition is 23.6%.^[3], nearly 2.5 times that of the non-ED population. Compared with men without ED, patients with ED exhibit higher absenteeism, greater work impairment due to illness, higher overall work productivity loss, and lower health-related quality of life. Furthermore, the long-standing societal sensitivity surrounding ED and the public’s one-sided understanding of men’s health make it difficult for many ED patients to speak out, often leading them to avoid seeking medical attention proactively.

Address by Professor Jiang Hui, President of the Chinese Society of Sexual Medicine and Director of the Department of Andrology and Human Sperm Bank at Peking University Third Hospital

Professor Jiang Hui, President of the Chinese Society of Sexual Medicine and Director of the Department of Andrology and Human Sperm Bank at Peking University Third Hospital, stated: “Erectile hardness is the primary factor determining couples’ satisfaction with their sexual life and achieving a perfect sexual experience. There are many factors contributing to male erectile dysfunction (ED), often involving the simultaneous interplay of multiple causes. Excessive stress and long-term unhealthy lifestyle habits are significant triggers for ED that should not be underestimated. Currently, ED is not merely an issue of ‘sexual well-being,’ but also a ‘health concern,’ and indeed a ‘social issue’ affecting families and public welfare. We advocate for early detection and treatment of ED, addressing patients’ emotional and physiological needs with due attention, and actively seeking solutions through formal medical channels, thereby safeguarding one’s health and ensuring a satisfying sexual life.”

Oral Disintegration,ED Medication: Privacy Worry-Free

Professor Jiang Hui pointed out, "The methods for treating ED are constantly evolving, from surgical treatments to pharmacological interventions, with oral PDE5 inhibitors remaining the first-line treatment option. Meanwhile, ED patients show a stronger preference for oral medications that are convenient to take, fast-acting, and offer good privacy. This time, Viagra^®The market launch of orally disintegrating tablets not only provides physicians with a first-line pharmacological option for the treatment of erectile dysfunction (ED), but also offers ED patients a safe, highly effective, and convenient new therapeutic experience. This contributes to improved patient adherence, enhances the quality of life for both patients and their partners, boosts male self-confidence, and delivers multidimensional benefits. The continuous research, development, and market introduction of therapeutic agents lay a favorable foundation for the advancement of andrology, helping more ED patients raise disease awareness and accept scientifically standardized treatment.

As the currently available product in the Chinese market that is bioequivalent to film-coated tabletsUniqueThe original PDE5 inhibitor, Viagra^®Orally disintegrating tablets are easy to administer, disintegrating within seconds when placed on the tongue. They take effect in as little as 12 minutes, improving symptoms in patients with erectile dysfunction (ED) while enhancing sexual quality of life.

Viagra’s 20 Years in China: Fueling New Advances in Men’s Health

2020 marked the 20th anniversary of Viagra’s launch in China. Over the years, we have collaborated with numerous authoritative experts in andrology to comprehensively advance men’s health in China and continuously strengthen public awareness regarding timely medical consultation and evidence-based treatment for andrological conditions.

Address by Miao Tianxiang, Chairman and President of Greater China, Pfizer

Miao Tianxiang, Chairman and President of Pfizer Upjohn Greater China, stated, “Pfizer Upjohn has been committed to improving the health of the Chinese people and actively collaborating with all sectors of society to jointly promote the development of men’s health in China.”Pfizer Upjohn'sOver the 20 years since Viagra was launched in China, its efficacy in treating erectile dysfunction (ED) has become widely recognized. Patients and their evolving needs remain at the core of all our endeavors. We hope to actively collaborate with all sectors of society to jointly promote the development of men’s health in China.”

Remarks by Ren Xiaoxiu, Vice President of Pfizer Upjohn’s Retail Business in China

Ren Xiaoxiu, Vice President of Pfizer Upjohn’s China Retail Business, stated, “Viagra, launched in China this time,^®“Imported from France, orally disintegrating tablets continuously innovate to meet the medication needs of Chinese patients. By providing a simple and convenient orally disintegrating tablet formulation, they fulfill patients’ demands for high-quality medications and professional, accessible services, thereby contributing new momentum to promoting men’s health and building harmonious, happy families.”

To help more men more conveniently access knowledge and professional services for achieving perfect sexual experiences, Viagra^®Following its market launch, the orally disintegrating tablets will be available on JD Health, with their online debut at the JD Pharmacy. This initiative aims to meet patients’ demands for high-quality products and professional, convenient medical consultations, thereby contributing new momentum to the advancement of men’s health.

[1] Capogrosso, P., et al.J Sex Med, 2013. 10: 1833
[2] Haocheng Lin et.al, Int J Clin Pract. 2020;74:e13417
[3] Goldstein I, Goren A, Maculaitis MC, Tang WY, Hassan TA. The association of erectile dysfunction with productivity and absenteeism in eight countries globally. Int J Clin Pract. 2019;e13384. http://doi.org/10.1111/ijcp.13384